Citius Pharmaceuticals, Inc. (CTXR)
0.4034
+0.03
(+8.79%)
USD |
NASDAQ |
Oct 23, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Price to Book Value : 0.1662 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.1662 |
| October 22, 2026 | 0.1528 |
| October 21, 2026 | 0.163 |
| October 20, 2026 | 0.1721 |
| October 19, 2026 | 0.1763 |
| October 16, 2026 | 0.1896 |
| October 15, 2026 | 0.1896 |
| October 14, 2026 | 0.1916 |
| October 13, 2026 | 0.1962 |
| October 12, 2026 | 0.2031 |
| October 09, 2026 | 0.2058 |
| October 08, 2026 | 0.2014 |
| October 07, 2026 | 0.2065 |
| October 06, 2026 | 0.1981 |
| October 05, 2026 | 0.2143 |
| October 02, 2026 | 0.2191 |
| October 01, 2026 | 0.2226 |
| September 30, 2026 | 0.2188 |
| September 29, 2026 | 0.2285 |
| September 28, 2026 | 0.2263 |
| September 25, 2026 | 0.2385 |
| September 24, 2026 | 0.235 |
| September 23, 2026 | 0.2343 |
| September 22, 2026 | 0.2465 |
| September 21, 2026 | 0.2376 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.2473 |
| September 17, 2026 | 0.2423 |
| September 16, 2026 | 0.2308 |
| September 15, 2026 | 0.2308 |
| September 14, 2026 | 0.2362 |
| September 11, 2026 | 0.2394 |
| September 10, 2026 | 0.2412 |
| September 09, 2026 | 0.2399 |
| September 08, 2026 | 0.2475 |
| September 04, 2026 | 0.2422 |
| September 03, 2026 | 0.2481 |
| September 02, 2026 | 0.2388 |
| September 01, 2026 | 0.2345 |
| August 31, 2026 | 0.2391 |
| August 28, 2026 | 0.2481 |
| August 27, 2026 | 0.2592 |
| August 26, 2026 | 0.2378 |
| August 25, 2026 | 0.2488 |
| August 24, 2026 | 0.2371 |
| August 21, 2026 | 0.2474 |
| August 20, 2026 | 0.2472 |
| August 19, 2026 | 0.2627 |
| August 18, 2026 | 0.2357 |
| August 17, 2026 | 0.2316 |
| August 14, 2026 | 0.3114 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| PS Ratio | 1.251 |
| Price | 0.4034 |
| Earnings Yield | -523.2% |
| Market Cap | 11.07M |